Document is current
Any future updates will be listed below
-
Authors
Liao, Chang
Mennillo, Elvira
Kattah, Michael G. https://orcid.org/0000-0002-6067-6585
Ji, Ming
Wang, Zhi-En
Drucker, Daniel J. https://orcid.org/0000-0001-6688-8127
Liang, Hong-Erh
Locksley, Richard M. https://orcid.org/0000-0002-5468-6867
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 3 October 2025
First Online: 12 November 2025
Competing interests
: D.J.D. is a party to a GLP-2 license agreement between Takeda Pharmaceuticals, the University Health Network and the University of Toronto. M.G.K. receives research support from Eli Lilly. M.G.K. has consulted for Sonoma Biotherapeutics, Morphic Therapeutic, Santa Ana Bio, Spyre, Cellarity, Vedanta and CytoMx, and he is on the scientific advisory board for Switchback Therapeutics. The other authors declare no competing interests.
